Fujian Cancer Hospital
3 clinical trials · 3 recruiting · OTHER_GOV
Trials by Fujian Cancer Hospital
RECRUITINGPhase 2 / Phase 3NCT05699655
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann...
To evaluate the clinical efficacy and safety of Tislelizumab combined with apatinib mesylate, oxaliplatin plus S1 Vs oxaliplatin plus S1.
Sponsor: Fujian Cancer HospitalEnrolling: 1301 location
Immunotherapy Gastrict Cancer
RECRUITINGPhase 2NCT05624099
Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.
This is a prospective single-arm exploratory clinical study. The efficacy and safety of camrelizumab combined with chemoradiotherapy and camrelizumab combined with chemotherapy...
Sponsor: Fujian Cancer HospitalEnrolling: 751 location
Esophageal NeoplasmsEsophageal DiseasesDigestive System Neoplasms
RECRUITINGNCT07142122
Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the...
This prospective, single-center, randomized, controlled, non-inferiority clinical trial aims to compare the safety and postoperative quality of life of early upper gastric cancer...
Sponsor: Fujian Cancer HospitalEnrolling: 761 location
Gastric Cancer